102 related articles for article (PubMed ID: 38748872)
1. Folic acid modified precision nanocarriers: charting new frontiers in breast cancer management beyond conventional therapies.
Nehal N; Rohilla A; Sartaj A; Baboota S; Ali J
J Drug Target; 2024 May; ():1-19. PubMed ID: 38748872
[TBL] [Abstract][Full Text] [Related]
2. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.
Choudhury H; Pandey M; Wen LP; Cien LK; Xin H; Yee ANJ; Lee NJ; Gorain B; Amin MCIM; Pichika MR
Curr Pharm Des; 2020; 26(42):5365-5379. PubMed ID: 32693762
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative Breast Cancer.
Ilyas S; E M Sahnoun S; Szymura A; Pes J; Habib S; Florea A; Schäfer L; Buhl EM; Morgenroth A; Habib P; Mottaghy FM; Mathur S
ACS Appl Mater Interfaces; 2023 Oct; 15(42):48963-48977. PubMed ID: 37831583
[TBL] [Abstract][Full Text] [Related]
5. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance/Infrared Dual-Modal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy Nanoplatform Based on Cu
Cheng L; Sang D; Zhao F; Yang L; Guo Z; Zhang X; Yang Q; Qiao W; Sun X; Guan X; Wang H; Wang J; Zou H; Li X; Fang F; Li Y; Zhang S; Wu L; Lin H; Sun X; Wang K
J Colloid Interface Sci; 2022 Jun; 615():95-109. PubMed ID: 35124510
[TBL] [Abstract][Full Text] [Related]
7. Folic Acid-Grafted Chitosan-Alginate Nanocapsules as Effective Targeted Nanocarriers for Delivery of Turmeric Oil for Breast Cancer Therapy.
San HHM; Alcantara KP; Bulatao BPI; Sorasitthiyanukarn FN; Nalinratana N; Suksamrarn A; Vajragupta O; Rojsitthisak P; Rojsitthisak P
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678739
[TBL] [Abstract][Full Text] [Related]
8. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer.
Ebrahimnejad P; Sodagar Taleghani A; Asare-Addo K; Nokhodchi A
Drug Discov Today; 2022 Feb; 27(2):471-489. PubMed ID: 34781032
[TBL] [Abstract][Full Text] [Related]
9. The Use of Lipid-Based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments.
Tantray J; Patel A; Prajapati BG; Kosey S; Bhattacharya S
Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38357950
[TBL] [Abstract][Full Text] [Related]
10. Folate-Targeted Anticancer Drug Delivery via a Combination Strategy of a Micelle Complex and Reducible Conjugation.
Wang M; Long J; Zhang S; Liu F; Zhang X; Zhang X; Sun L; Ma L; Yu C; Wei H
ACS Biomater Sci Eng; 2020 Mar; 6(3):1565-1572. PubMed ID: 33455375
[TBL] [Abstract][Full Text] [Related]
11. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density.
Tang Z; Li D; Sun H; Guo X; Chen Y; Zhou S
Biomaterials; 2014 Sep; 35(27):8015-27. PubMed ID: 24947231
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of HPLC method for simultaneous determination of Leflunomide and folic acid in the nanoparticulate system by reversed-phase HPLC.
Siddiqui B; Ahmed H; Haq IU; Rehman AU; Ahmed N
Drug Dev Ind Pharm; 2023 Aug; 49(8):497-507. PubMed ID: 37470519
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.
Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E
Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218
[TBL] [Abstract][Full Text] [Related]
14. The anti-tumor and renoprotection study of E-[c(RGDfK)
Zhang B; Zhang Y; Dang W; Xing B; Yu C; Guo P; Pi J; Deng X; Qi D; Liu Z
J Nanobiotechnology; 2022 Sep; 20(1):425. PubMed ID: 36153589
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy.
Ranjbar-Navazi Z; Eskandani M; Johari-Ahar M; Nemati A; Akbari H; Davaran S; Omidi Y
J Drug Target; 2018 Mar; 26(3):267-277. PubMed ID: 28795849
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional folic-conjugated aspartic-modified Fe
Khalil M; Haq EA; Dwiranti A; Prasedya ES; Kitamoto Y
RSC Adv; 2022 Feb; 12(8):4961-4971. PubMed ID: 35425526
[TBL] [Abstract][Full Text] [Related]
17. Innovative approaches for cancer treatment: graphene quantum dots for photodynamic and photothermal therapies.
Zarepour A; Khosravi A; Yücel Ayten N; Çakır Hatır P; Iravani S; Zarrabi A
J Mater Chem B; 2024 May; 12(18):4307-4334. PubMed ID: 38595268
[TBL] [Abstract][Full Text] [Related]
18. Design of novel polyurethane-based ionene nanocarriers for cancer therapy: Synthesis, in-vitro, and in-vivo studies.
Mahdieh A; Yeganeh H; Sande SA; Nyström B
Int J Pharm; 2023 Mar; 635():122768. PubMed ID: 36841369
[TBL] [Abstract][Full Text] [Related]
19. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
20. Folic acid modified cell membrane capsules encapsulating doxorubicin and indocyanine green for highly effective combinational therapy in vivo.
Li X; Zhao X; Pardhi D; Wu Q; Zheng Y; Zhu H; Mao Z
Acta Biomater; 2018 Jul; 74():374-384. PubMed ID: 29734009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
